XML 25 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value of Financial Instruments
12 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

5. Fair Value of Financial Instruments

The Company’s financial instruments generally include cash and cash equivalents, short-term investments, trade accounts, financing receivables and accounts payable.  Due to the short-term maturities of cash and cash equivalents, trade accounts receivable, financing receivables and accounts payable, the carrying amounts approximate fair value on the respective balance sheet dates.  The valuation technique used to measure the fair value of the contingent consideration was derived from models utilizing market observable inputs.  

The Company measures its short-term investments and contingent consideration at fair value on a recurring basis.

The following tables present the fair value of the Company’s short-term investments and contingent consideration by valuation hierarchy and input (in thousands):

 

 

 

AS OF SEPTEMBER 30, 2021

 

 

 

Quoted Prices

in Active

Markets for

Identical Assets

(Level 1)

 

 

Significant Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate bonds

 

$

 

 

$

9,496

 

 

$

 

 

$

9,496

 

Total assets

 

$

 

 

$

9,496

 

 

$

 

 

$

9,496

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Contingent consideration liabilities

 

 

 

 

 

 

 

 

(5,210

)

 

 

(5,210

)

Total liabilities

 

$

 

 

$

 

 

$

(5,210

)

 

$

(5,210

)

 

 

 

AS OF SEPTEMBER 30, 2020

 

 

 

Quoted Prices

in Active

Markets for

Identical Assets

(Level 1)

 

 

Significant Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Contingent consideration

 

$

 

 

$

 

 

$

(10,962

)

 

$

(10,962

)

 

 

The following table summarizes changes in the fair value of the Company’s Level 3 financial instruments for the fiscal years ended September 30, 2020 and 2021:

 

Balance at October 1, 2019

 

$

9,940

 

Fair value adjustments

 

 

1,100

 

Payment of contingent consideration

 

 

(78

)

Balance at September 30, 2020

 

 

10,962

 

Fair value adjustments

 

 

(3,524

)

Payment of contingent consideration

 

 

(1,421

)

 

 

 

6,017

 

Less:  Consideration payable

 

 

(807

)

Balance at September 30, 2021

 

$

5,210

 

 

Adjustments to the fair value of the contingent consideration are based on Monte Carlo simulations or the probability-weighted expected return method utilizing inputs which include market comparable information and management assessments regarding potential future scenarios.  The Company believes its estimates and assumptions are reasonable, however, there is significant judgment involved.